In the Framingham population study (n = 3523, mean 62 y, 53% F) over nearly 30 years, higher IGFBP-1, IGFBP-2 and IGF-I predicted cardiovascular disease mortality [57]. This evidence concerns the gene IGF1 and cardiovascular disorder.